Chris Clark

Chris Clark has extensive experience in finance and leadership roles. Chris is currently serving as the Chief Financial Officer at D2V Clinical, starting in February 2023. Prior to this, they held the same role at Curadh MTR, starting in October 2021. Chris has also served as a Board Trustee at Worldwide Cancer Research since March 2020. In their earlier career, they held various Chief Financial Officer positions at MedSource, Chiltern, and Ockham, from 2016 to 2022, 2014 to 2016, and 2012 to 2014, respectively. Chris was also the Finance Director at Nexus Oncology Ltd from August 2011 to April 2012. Chris started their career as an Audit Senior at Ernst & Young from 1999 to 2003 and then worked as the Financial Controller at Ardana plc from September 2003 to May 2008. Chris later became an Associate Director of Corporate Finance at Springfords from May 2008 to July 2011. Overall, Chris Clark has a strong background in finance and a proven track record in executive roles.

Chris Clark attended Loretto from 1989 to 1994, but no specific degree or field of study information was provided. Chris then went on to study Economics & Management at the University of Aberdeen from 1995 to 1999, where they earned a degree in MA (Hons).